{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T23:42:31Z","timestamp":1792539751325,"version":"4.5.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,2,5]],"date-time":"2021-02-05T00:00:00Z","timestamp":1612483200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Saudi Pharmaceutical Journal"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.jsps.2021.02.001","type":"journal-article","created":{"date-parts":[[2021,2,17]],"date-time":"2021-02-17T16:36:54Z","timestamp":1613579814000},"page":"487-496","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Commonly used agent for acute pain management of sickle cell anemia in Saudi Emergency Department: A narrative review"],"prefix":"10.1007","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9570-8161","authenticated-orcid":false,"given":"Reem A.","family":"Hejazi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nameer A.","family":"Mandourah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aryaf S.","family":"Alsulami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hussain T.","family":"Bakhsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reem M.","family":"Diri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad O.","family":"Noor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"10.1016\/j.jsps.2021.02.001_b0005","unstructured":"Alaa Al-Anazi LA-S, Maha Al-Ammari , Tariq Al-Debasi , Abdulmalik M. Alkatheri , Shmeylan Al-Harbi , Aiman A. Obaidat , et al. Assessment of patient-controlled analgesia versus intermittent opioid therapy to manage sickle-cell disease vaso-occlusive crisis in adult patients. Saudi J Anaesth2017 Oct-Dec."},{"key":"10.1016\/j.jsps.2021.02.001_b0010","unstructured":"Mohieldin Elsayid MJA-S, Yasser Abdullah Alkulaibi , Abdullah Alanazi , and Shoeb Qureshi. Frequency distribution of sickle cell anemia, sickle cell trait and sickle\/beta-thalassemia among anemic patients in Saudi Arabia. 2015 Aug."},{"key":"10.1016\/j.jsps.2021.02.001_b0015","doi-asserted-by":"crossref","DOI":"10.4103\/1817-1737.36550","article-title":"Sickle cell disease patients in eastern province of Saudi Arabia suffer less severe acute chest syndrome than patients with African haplotypes","author":"Alabdulaali","year":"2007","journal-title":"Ann Thorac Med"},{"key":"10.1016\/j.jsps.2021.02.001_b0020","doi-asserted-by":"crossref","DOI":"10.4103\/0256-4947.81540","article-title":"Epidemiology of sickle cell disease in Saudi Arabia","author":"Jastaniah","year":"2011","journal-title":"Ann Saudi Med"},{"key":"10.1016\/j.jsps.2021.02.001_b0025","article-title":"Causes of hospitalization in sickle cell diseased children in western region of Saudi Arabia. A single center study","author":"Abd","year":"2019","journal-title":"Saudi Med J"},{"issue":"2","key":"10.1016\/j.jsps.2021.02.001_b0030","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jegh.2016.12.006","article-title":"Sickle cell disease in Saudi Arabia: A challenge or not","volume":"7","author":"Alotaibi","year":"2019","journal-title":"Journal of epidemiology and global health"},{"key":"10.1016\/j.jsps.2021.02.001_b0035","unstructured":"Rodgers GP. Hydroxyurea and other disease-modifying therapies in sickle cell disease. UpToDate. Schrier SL, Mahoney DH and Tirnauer JS (Eds). 2014."},{"key":"10.1016\/j.jsps.2021.02.001_b0040","doi-asserted-by":"crossref","unstructured":"Estcourt LJ, Fortin PM, Hopewell S, Trivella M. Red blood cell transfusion to treat or prevent complications in sickle cell disease: an overview of Cochrane reviews. The Cochrane database of systematic reviews. 2016 Feb 8;2016(2).","DOI":"10.1002\/14651858.CD012082"},{"key":"10.1016\/j.jsps.2021.02.001_b0045","series-title":"Overview of the clinical manifestations of sickle cell disease","author":"Vichinsky","year":"2014"},{"key":"10.1016\/j.jsps.2021.02.001_b0050","unstructured":"Complications and Treatments of Sickle Cell Disease | CDC [Internet]. Centers for Disease Control and Prevention. 2019 [cited 9 December 2019]. Available from: https:\/\/www.cdc.gov\/ncbddd\/sicklecell\/treatments.html#Pain"},{"key":"10.1016\/j.jsps.2021.02.001_b0055","doi-asserted-by":"crossref","unstructured":"Strouse J. Sickle cell disease. InHandbook of clinical neurology 2016 Jan 1 (Vol. 138, pp. 311-324). Elsevier.","DOI":"10.1016\/B978-0-12-802973-2.00018-5"},{"issue":"3","key":"10.1016\/j.jsps.2021.02.001_b0060","first-page":"179","article-title":"Pain management in adult acute sickle cell pain crisis: a view point","volume":"26","author":"Udezue","year":"2007","journal-title":"West African journal of medicine."},{"issue":"2","key":"10.1016\/j.jsps.2021.02.001_b0065","doi-asserted-by":"crossref","first-page":"115","DOI":"10.5144\/0256-4947.2005.115","article-title":"Observations on the management of acute pain crisis in adult sickle cell disease in eastern Saudi Arabia","volume":"25","author":"Udezue","year":"2005","journal-title":"Annals of Saudi medicine."},{"issue":"4","key":"10.1016\/j.jsps.2021.02.001_b0070","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1177\/1076029609352661","article-title":"Management of painful vaso-occlusive crisis of sickle-cell anemia: consensus opinion","volume":"16","author":"Mousa","year":"2010","journal-title":"Clinical and Applied Thrombosis\/Hemostasis."},{"issue":"2","key":"10.1016\/j.jsps.2021.02.001_b0075","doi-asserted-by":"crossref","first-page":"97","DOI":"10.5144\/0256-4947.1999.97","article-title":"Isoxsuprine in the treatment of sickle cell painful crises: a double-blind comparative study with narcotic analgesic","volume":"19","author":"Al-Jam'a","year":"1999","journal-title":"Annals of Saudi medicine."},{"issue":"2","key":"10.1016\/j.jsps.2021.02.001_b0080","first-page":"152","article-title":"Pain management of children and adolescents with sickle cell disease presenting to the emergency department","volume":"32","author":"Taha","year":"2011","journal-title":"Saudi Med J."},{"issue":"08","key":"10.1016\/j.jsps.2021.02.001_b0085","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1160\/Th06-12-0718","article-title":"Reduction of painful vaso-occlusive crisis of sickle cell anaemia by tinzaparin in a double-blind randomized trial","volume":"98","author":"Qari","year":"2007","journal-title":"Thrombosis and haemostasis."},{"issue":"5","key":"10.1016\/j.jsps.2021.02.001_b0090","first-page":"1349","article-title":"Approach to Vaso-occlussive Crisis in Adults with Sickle Cell Disease","volume":"61","author":"Yale","year":"2000","journal-title":"American family physician."},{"issue":"5","key":"10.1016\/j.jsps.2021.02.001_b0095","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1046\/j.1365-2141.2003.04193.x","article-title":"Guidelines for the management of the acute painful crisis in sickle cell disease","volume":"120","author":"Rees","year":"2003","journal-title":"British journal of haematology."},{"issue":"9","key":"10.1016\/j.jsps.2021.02.001_b0100","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1177\/014107680209500909","article-title":"Management of pain in sickle-cell disease","volume":"95","author":"Okpala","year":"2002","journal-title":"Journal of the Royal Society of Medicine."},{"issue":"3","key":"10.1016\/j.jsps.2021.02.001_b0105","doi-asserted-by":"crossref","first-page":"179","DOI":"10.5144\/0256-4947.2004.179","article-title":"Differences between males and females in adult sickle cell pain crisis in eastern Saudi Arabia","volume":"24","author":"Udezue","year":"2004","journal-title":"Annals of Saudi medicine."},{"issue":"2","key":"10.1016\/j.jsps.2021.02.001_b0110","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1161\/01.CIR.0000044943.12533.A8","article-title":"Divergent nitric oxide bioavailability in men and women with sickle cell disease","volume":"107","author":"Gladwin","year":"2003","journal-title":"Circulation."},{"issue":"5","key":"10.1016\/j.jsps.2021.02.001_b0115","first-page":"28","article-title":"Gender differences in response to drugs: pain medications","volume":"2","author":"Schwartz","year":"1999","journal-title":"The journal of gender-specific medicine: JGSM: the official journal of the Partnership for Women's Health at Columbia."},{"issue":"1","key":"10.1016\/j.jsps.2021.02.001_b0120","first-page":"30","article-title":"Pain Management in Patients with Sickle Cell Disease-A Review","volume":"1","author":"Delicou","year":"2013","journal-title":"Hematology."},{"key":"10.1016\/j.jsps.2021.02.001_b0125","doi-asserted-by":"crossref","unstructured":"Steinberg MH. Management of sickle cell disease. New England Journal of Medicine. 1999 Apr 1;340(13):1021-..","DOI":"10.1056\/NEJM199904013401307"},{"issue":"10","key":"10.1016\/j.jsps.2021.02.001_b0130","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1001\/jama.2014.10517","article-title":"Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members","volume":"312","author":"Yawn","year":"2014","journal-title":"Jama."},{"issue":"5","key":"10.1016\/j.jsps.2021.02.001_b0135","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1093\/pch\/pxz022","article-title":"Evaluation of a clinical protocol using intranasal fentanyl for treatment of vaso-occlusive crisis in sickle cell patients in the emergency department","volume":"25","author":"Paquin","year":"2020","journal-title":"Paediatrics & Child Health."},{"issue":"7","key":"10.1016\/j.jsps.2021.02.001_b0140","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1034\/j.1399-6576.2002.460702.x","article-title":"Nasal administration of opioids for pain management in adults","volume":"46","author":"Dale","year":"2002","journal-title":"Acta anaesthesiologica scandinavica."},{"issue":"6","key":"10.1016\/j.jsps.2021.02.001_b0145","doi-asserted-by":"crossref","first-page":"e26332","DOI":"10.1002\/pbc.26332","article-title":"Intranasal fentanyl for initial treatment of vaso-occlusive crisis in sickle cell disease","volume":"64","author":"Fein","year":"2017","journal-title":"Pediatric blood & cancer."},{"issue":"3","key":"10.1016\/j.jsps.2021.02.001_b0150","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1542\/peds.2010-0616","article-title":"Intranasal medication delivery for children: a brief review and update","volume":"126","author":"Wolfe","year":"2010","journal-title":"Pediatrics."},{"key":"10.1016\/j.jsps.2021.02.001_b0155","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/768796","article-title":"A review of transbuccal fentanyl use in the emergency department","volume":"2012","author":"Arthur","year":"2012","journal-title":"Pain research and treatment."},{"issue":"6","key":"10.1016\/j.jsps.2021.02.001_b0160","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1111\/papr.12313","article-title":"Fentanyl buccal tablet: a new breakthrough pain medication in early Management of Severe Vaso-Occlusive Crisis in sickle cell disease","volume":"16","author":"De Franceschi","year":"2016","journal-title":"Pain Practice."},{"issue":"1","key":"10.1016\/j.jsps.2021.02.001_b0165","doi-asserted-by":"crossref","first-page":"e14","DOI":"10.1097\/01.mej.0000697876.99952.13","article-title":"38. Ketamine for painful sickle cell vaso-occlusive crises: a systematic review and meta-analysis","volume":"27","author":"Alghamdi","year":"2020","journal-title":"European Journal of Emergency Medicine."},{"issue":"11","key":"10.1016\/j.jsps.2021.02.001_b0170","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1111\/acem.12510","article-title":"Low-dose ketamine improves pain relief in patients receiving intravenous opioids for acute pain in the emergency department: results of a randomized, double-blind, clinical trial","volume":"21","author":"Beaudoin","year":"2014","journal-title":"Academic Emergency Medicine."},{"issue":"1","key":"10.1016\/j.jsps.2021.02.001_b0175","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13063-019-3394-4","article-title":"Study protocol for a randomized, blinded, controlled trial of ketamine for acute painful crisis of sickle cell disease","volume":"20","author":"Alshahrani","year":"2019","journal-title":"Trials."},{"key":"10.1016\/j.jsps.2021.02.001_b0180","unstructured":"https:\/\/www.centerwatch.com\/clinical-trials\/listings\/247682\/sickle-cell-crisis-low-dose-ketamine-acute\/?&radius=50&query=acute-pain&rnk=2"},{"key":"10.1016\/j.jsps.2021.02.001_b0185","unstructured":"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03502421"},{"issue":"5","key":"10.1016\/j.jsps.2021.02.001_b0190","first-page":"456","article-title":"Consensus guidelines on the use of intravenous ketamine infusions for acute pain management from the American Society of Regional Anesthesia and Pain Medicine, the American Academy of Pain Medicine, and the American Society of Anesthesiologists","volume":"43","author":"Schwenk","year":"2018","journal-title":"Regional Anesthesia & Pain Medicine."},{"issue":"5","key":"10.1016\/j.jsps.2021.02.001_b0195","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1007\/s00277-013-1954-3","article-title":"Ketamine infusion for sickle cell pain crisis refractory to opioids: a case report and review of literature","volume":"93","author":"Uprety","year":"2014","journal-title":"Annals of hematology."},{"issue":"1","key":"10.1016\/j.jsps.2021.02.001_b0200","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1080\/15360288.2018.1468383","article-title":"Low-dose ketamine infusion for adjunct management during vaso-occlusive episodes in adults with sickle cell disease: a case series","volume":"32","author":"Palm","year":"2018","journal-title":"Journal of pain & palliative care pharmacotherapy."},{"issue":"7","key":"10.1016\/j.jsps.2021.02.001_b0205","doi-asserted-by":"crossref","first-page":"e017190","DOI":"10.1136\/bmjopen-2017-017190","article-title":"Subdissociative intranasal ketamine plus standard pain therapy versus standard pain therapy in the treatment of paediatric sickle cell disease vaso-occlusive crises in resource-limited settings: study protocol for a randomised controlled trial","volume":"7","author":"Young","year":"2017","journal-title":"BMJ open"},{"issue":"4","key":"10.1016\/j.jsps.2021.02.001_b0210","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1097\/SPC.0000000000000437","article-title":"Ketamine and lidocaine infusions decrease opioid consumption during vaso-occlusive crisis in adolescents with sickle cell disease","volume":"13","author":"Puri","year":"2019","journal-title":"Current opinion in supportive and palliative care."},{"issue":"4","key":"10.1016\/j.jsps.2021.02.001_b0215","doi-asserted-by":"crossref","first-page":"359","DOI":"10.3109\/15360288.2015.1082009","article-title":"Intravenous lidocaine as an adjuvant for pain associated with sickle cell disease","volume":"29","author":"Nguyen","year":"2015","journal-title":"Journal of pain & palliative care pharmacotherapy."},{"key":"10.1016\/j.jsps.2021.02.001_b0220","unstructured":"Choudhuri S, Ray B, Mohanty D. Medical Reports and Case Studies."},{"key":"10.1016\/j.jsps.2021.02.001_b0225","article-title":"Inhaled nitric oxide for treating pain crises in people with sickle cell disease","volume":"10","author":"Aboursheid","year":"2019","journal-title":"Cochrane Database of Systematic Reviews."},{"key":"10.1016\/j.jsps.2021.02.001_b0230","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.2147\/JPR.S252222","article-title":"Role of inhaled methoxyflurane in the management of acute trauma pain","volume":"13","author":"Fabbri","year":"2020","journal-title":"Journal of pain research."},{"issue":"11","key":"10.1016\/j.jsps.2021.02.001_b0235","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1016\/j.ajem.2015.06.014","article-title":"Efficacy and safety of nebulized morphine given at 2 different doses compared to IV titrated morphine in trauma pain","volume":"33","author":"Grissa","year":"2015","journal-title":"The American journal of emergency medicine."},{"issue":"2","key":"10.1016\/j.jsps.2021.02.001_b0240","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1002\/ajh.20064","article-title":"Management of acute chest wall sickle cell pain with nebulized morphine","volume":"76","author":"Ballas","year":"2004","journal-title":"American journal of hematology."}],"container-title":["Saudi Pharmaceutical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1319016421000281?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1319016421000281?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T17:25:52Z","timestamp":1736184352000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1319016421000281"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":48,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["S1319016421000281"],"URL":"https:\/\/doi.org\/10.1016\/j.jsps.2021.02.001","relation":{},"ISSN":["1319-0164"],"issn-type":[{"value":"1319-0164","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Commonly used agent for acute pain management of sickle cell anemia in Saudi Emergency Department: A narrative review","name":"articletitle","label":"Article Title"},{"value":"Saudi Pharmaceutical Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsps.2021.02.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier B.V. on behalf of King Saud University.","name":"copyright","label":"Copyright"}]}}